中国中医药信息杂志2024，Vol.31Issue(7)：188-192,5.DOI:10.19879/j.cnki.1005-5304.202306058
中药干预"双心疾病"临床研究进展
Clinical Research Progress in TCM Intervention in "Psycho-cardiological Disease"
摘要
Abstract
In recent years,with the increase of social pressure,the incidence of"psycho-cardiological disease"increases.Western medicine mainly uses conventional cardiovascular drugs combined with antidepressant or anxiety drugs.TCM has the characteristics of multi-pathway,multi-target,multi-mechanism,integration and low toxicity.It has unique advantages in the intervention of"psycho-cardiological disease"and has significant clinical efficacy.However,the pathogenesis,clinical diagnosis,syndrome differentiation and treatment of this disease are not the same.This article summarized relevant literature and reviewed the etiology,pathogenesis,experience in syndrome differentiation and treatment,and clinical research of this disease from the perspective of TCM,in order to provide reference for diagnosis of disease,precision treatment and improvement of curative efficacy of"psycho-cardiological disease".关键词
双心疾病/中药/临床研究/辨证论治/综述Key words
psycho-cardiological disease/TCM/clinical research/syndrome differentiation and treatment/review分类
医药卫生引用本文复制引用
廉坤,李琳,宁博,胡思远,卢彦杰,胡志希..中药干预"双心疾病"临床研究进展[J].中国中医药信息杂志,2024,31(7):188-192,5.基金项目
国家自然科学基金(82274412) （82274412）
广东省重点领域研发项目(2020B1111100001) （2020B1111100001）
湖南省自然科学基金(2020JJ4062、2020JJ5408) （2020JJ4062、2020JJ5408）
